Figure S1 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

<p>The establishment of gefitinib-resistant cell lines, genomic alterations information of resistant patients, and the effect of MYLK-AS1 on the drug resistance of sensitive cells.</p>

Authors

Publication Details

Published
2025-08-15
DOI
https://doi.org/10.1158/0008-5472.29919069
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Figure S1 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

Lei Song, Xiyi Lu, Tianyu Qu, Chen Zhang et al.
Cancer, Hypoxia, and Metabolism
article

Figure S1 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

Lei Song, Xiyi Lu, Tianyu Qu, Chen Zhang, Erbao Zhang, Dandan Yin, Jiali Dai, Renhua Guo, Jiali Xu
article en

Abstract

<p>The establishment of gefitinib-resistant cell lines, genomic alterations information of resistant patients, and the effect of MYLK-AS1 on the drug resistance of sensitive cells.</p>

Openalex Percentile: Top 72%
Cancer, Hypoxia, and Metabolism
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Figure S1 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer — Lei Song, Xiyi Lu, et al. · (2025) | TGRS Research Map | TGRS